These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6260864)

  • 81. The influence of long-term treatment with mecillinam on fecal Escherichia coli.
    Møller JK; Stenderup A
    Scand J Infect Dis; 1984; 16(2):223-4. PubMed ID: 6330882
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synergy and mecillinam.
    Gray J
    J Antimicrob Chemother; 1977 Nov; 3(6):531-3. PubMed ID: 202586
    [No Abstract]   [Full Text] [Related]  

  • 83. [Combined antimicrobial action of mecillinam and ampicillin].
    Khantimer EI
    Antibiotiki; 1983 Aug; 28(8):589-91. PubMed ID: 6314880
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The two sites of penicillin action in Escherichia coli.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Dec; 128(6):791-4. PubMed ID: 4358124
    [No Abstract]   [Full Text] [Related]  

  • 85. Pathway-Directed Screen for Inhibitors of the Bacterial Cell Elongation Machinery.
    Buss JA; Baidin V; Welsh MA; Flores-Kim J; Cho H; Wood BM; Uehara T; Walker S; Kahne D; Bernhardt TG
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323039
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cyclic AMP and cell division in Escherichia coli.
    D'Ari R; Jaffé A; Bouloc P; Robin A
    J Bacteriol; 1988 Jan; 170(1):65-70. PubMed ID: 2826407
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mecillinam and ampicillin separately or combined in gram-negative septicemia.
    Ekwall E; Scheja A; Cronberg S; Ganrot-Norlin K; Jonsson M; Juhlin I; Kahlmeter G; Thorén A; Thulin KE; Tunevall G
    Infection; 1980; 8(1):37-40. PubMed ID: 6246006
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Studies on the effect of mecillinam upon Micrococcaceae and faecal streptococci under conditions simulating urinary tract infection.
    Anderson JD; Adams MA; Wilson LC; Shepherd CA
    J Antimicrob Chemother; 1976 Dec; 2(4):351-61. PubMed ID: 206530
    [No Abstract]   [Full Text] [Related]  

  • 89. Paradoxical effect of mecillinam on Providencia stuartii.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1976 Dec; 2(4):386-8. PubMed ID: 206531
    [No Abstract]   [Full Text] [Related]  

  • 90. In vitro study of the susceptibility of Escherichia coli to mecillinam.
    Bjerager L; Skov R; Frimodt-Møller N
    J Antimicrob Chemother; 2000 Jun; 45(6):920-1. PubMed ID: 10837453
    [No Abstract]   [Full Text] [Related]  

  • 91. Morphology of an Escherichia coli mutant with a temperature-dependent round cell shape.
    Iwaya M; Goldman R; Tipper DJ; Feingold B; Strominger JL
    J Bacteriol; 1978 Dec; 136(3):1143-58. PubMed ID: 363690
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genetic analysis of mecillinam-resistant mutants of Caulobacter crescentus deficient in stalk biosynthesis.
    Seitz LC; Brun YV
    J Bacteriol; 1998 Oct; 180(19):5235-9. PubMed ID: 9748460
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro.
    Tybring L; Melchior NH
    Antimicrob Agents Chemother; 1975 Sep; 8(3):271-6. PubMed ID: 170856
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinical pharmacology of mecillinam in calves.
    Soback S; Bor A; Paz R; Ziv G
    J Vet Pharmacol Ther; 1986 Dec; 9(4):385-93. PubMed ID: 3543397
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of the binding properties of two 6 beta-amidinopenicillanic acid derivatives that differ in their physiological effects on Escherichia coli.
    Spratt BG
    Antimicrob Agents Chemother; 1977 Jan; 11(1):161-6. PubMed ID: 189683
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Rapid flow cytometric assessment of mecillinam and ampicillin bacterial susceptibility.
    Walberg M; Gaustad P; Steen HB
    J Antimicrob Chemother; 1996 Jun; 37(6):1063-75. PubMed ID: 8836810
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of osmolality on the response of Escherichia coli to mecillinam.
    Greenwood D
    Antimicrob Agents Chemother; 1976 Nov; 10(5):824-6. PubMed ID: 795371
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study.
    Klastersky J; Coppens L; Meunier-Carpentier F; Menday AP
    Antimicrob Agents Chemother; 1980 Sep; 18(3):437-42. PubMed ID: 6252835
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Mecillinam (Selexidin) in the treatment of neonates.
    de Louvois J; Mulhall A; Hurley R
    J Perinat Med; 1981; 9(2):87-95. PubMed ID: 6264060
    [No Abstract]   [Full Text] [Related]  

  • 100. Amdinocillin.
    Farrar WE
    Ann Intern Med; 1984 Sep; 101(3):389-90. PubMed ID: 6087706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.